2009.09.24 Weekly Broadcast Email
The following updates were made to the website for the week of September 21, 2009.
2009 Annual Meeting: Research Base Offices Closed
The CCCWFU CCOP Research Base offices will be closed until Monday, September 28, 2009 due to our annual meeting being held September 24-26, 2009 at the Renaissance Hotel in Asheville, NC. See you in Asheville!
60A02: (A Phase II Randomized Placebo Controlled, Double Blinded Trial to Evaluate the Effects of Fruit and Vegetable Extracts on Intermediate Biomarkers in Head and Neck Cancer Patients)
Amendment 15 has been added to the website. This amendment includes only minor changes requested by the WFU IRB.
Featured Study: Phase III Double Blind, Placebo Controlled Study of Donepezil in Irradiated Brain Tumor Patients
Have you considered opening 91105 at your site? Has your site accrued patients to this study recently? You might be interested to know…
Several recent protocol changes have been made to study 91105, Phase III Double Blind, Placebo Controlled Study of Donepezil in Irradiated Brain Tumor Patients. These changes were made to facilitate and simplify enrollment which include:
-Adding a $40 gift for participating
-Simplifying and reducing medication exclusions
Visit the recently updated 91105 webpage to view:
• Letter from the PI, Dr. Steve Rapp
• Brochure outlining recent changes
• Training video
97106 (Randomized Study to Determine whether ArginMax Improves the Sexual Function and Quality of Life in Female Cancer Survivors) only has 12 minority accrual slots open for patient accruals. We would like to see this study close by the end of the summer, so if you have patients that may be eligible for this study, please try and get them registered by then.
Sarah C. Hahne, CCRP
Protocol Information Office
CCCWFU CCOP Research Base
Wake Forest University School of Medicine
Medical Center Boulevard
Winston Salem, NC 27157
Office Hours: Monday and Wednesday 8-5